Elk Creek Partners’s Integra LifeSciences IART Stock Holding History

Elk Creek Partners’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-156,141	Closed	-$3.17M	–	159
2014 Q3	$3.17M	Buy	156,141 +31,209	+25%	+$621K	0.83%	59
2014 Q2	$2.4M	Buy	+124,932	New	+$2.33M	0.65%	86

Other funds holding IART

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Elk Creek Partners's IART Position: Q4 2014 in Review

Elk Creek Partners sold out of Integra LifeSciences (IART) in Q4 2014, closing a stake of 156,141 shares — an estimated $3.17M sold.

Elk Creek Partners first reported a position in IART in Q2 2014 and held it in 2 quarters. The position peaked at $3.17M in Q3 2014. 158 funds tracked by Wall St. Rank hold IART as of Q4 2014.

Elk Creek Partners reported no remaining Integra LifeSciences position as of Q4 2014 after selling out during the quarter.
Elk Creek Partners sold 156,141 Integra LifeSciences shares in Q4 2014, an estimated $3.17M.
Elk Creek Partners first reported a position in Integra LifeSciences in Q2 2014 and held it in 2 quarters.
Elk Creek Partners's Integra LifeSciences position peaked at $3.17M in Q3 2014.
158 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2014.

Based on Elk Creek Partners's 13F filing for Q4 2014, filed 13 Feb 2015.